Name: Sanofi India Ltd Financial Filings and Reports
Creator: FinancialReports
License: https://financialreports.eu/terms/

Filings indexed 1,552 across all filing types

Latest filing 2024-02-23 Regulatory Filings

Country IN India

Listing BSE.NS SANOFI

About Sanofi India Ltd

https://www.sanofi.in

Sanofi India Ltd focuses on the development, manufacturing, and marketing of a wide range of pharmaceutical products and healthcare solutions. The company operates across several therapeutic areas, including diabetes, cardiology, thrombosis, central nervous system disorders, and consumer healthcare. Its product portfolio includes established brands such as Lantus, Allegra, Combiflam, Amaryl, Avil, and Enterogermina. The organization prioritizes chronic disease management and acute care through a combination of prescription medicines and over-the-counter treatments. By integrating global research capabilities with local manufacturing excellence, the company provides specialized medical solutions aimed at improving patient health outcomes and addressing unmet medical needs.

Recent filings

Filing	Released	Lang
Record Date Regulatory Filings	2024-02-23	English
Record Date Regulatory Filings	2024-02-23	English
The Record date for the Interim Dividend shall be 7th March, 2024 and for the Final Dividend shall be 3rd May, 2024. Regulatory Filings	2024-02-23	English
The Board, at its meeting held on 23rd February, 2024, has declared an Interim Dividend of Rs. 50 per equity share and recommended a Final Dividend of Rs. 117 per equity share. Regulatory Filings	2024-02-23	English
The Board, at its meeting held on 23rd February, 2024, has declared an Interim Dividend of Rs. 50 per equity share and recommended a Final Dividend of Rs. 117 per equity share. Kindly .... Regulatory Filings	2024-02-23	English
We enclose a copy of the Auditor''s report and Audited Standalone and Consolidated Financial Results of the Company for the Financial Year ended 31st December 2023 along with Statement .... Regulatory Filings	2024-02-23	English

Browse filings by year

17 years

	ID	Filing	Released	Lang
2024 15 filings
	42672102	Record Date Regulatory Filings	2024-02-23	English
	42672163	Record Date Regulatory Filings	2024-02-23	English
	45833330	The Record date for the Interim Dividend shall be 7th March, 2024 and for the Final Dividend shall be 3rd May, 2024. Regulatory Filings	2024-02-23	English
	45833209	The Board, at its meeting held on 23rd February, 2024, has declared an Interim Dividend of Rs. 50 per equity share and recommended a Final Dividend of Rs. 117 per equity share. Regulatory Filings	2024-02-23	English
	45833714	The Board, at its meeting held on 23rd February, 2024, has declared an Interim Dividend of Rs. 50 per equity share and recommended a Final Dividend of Rs. 117 per equity share. Kindly .... Regulatory Filings	2024-02-23	English
	45833468	We enclose a copy of the Auditor''s report and Audited Standalone and Consolidated Financial Results of the Company for the Financial Year ended 31st December 2023 along with Statement .... Regulatory Filings	2024-02-23	English
	42672881	Outcome of Board Meeting Regulatory Filings	2024-02-23	English
	42672767	Dividend Regulatory Filings	2024-02-23	English
	42672719	Dividend Regulatory Filings	2024-02-23	English
	45833591	We enclose a copy of the Auditor''s Report and Audited Standalone and Consolidated Financial Results of the Company for the Financial Year ended 31st December 2023 along with the statement .... Regulatory Filings	2024-02-23	English
	42673650	Financial Result Updates Regulatory Filings	2024-02-23	English
	42655725	Updates Board/Management Information	2024-02-22	English
	45833832	We wish to clarify that each of the said appointments of Independent Directors of Sanofi Consumer Healthcare India Limited, a wholly owned subsidiary of the Company, are effective from .... Board/Management Information	2024-02-22	English
	42663230	Updates Regulatory Filings	2024-02-21	English
	45833858	Please find enclosed intimation from Sanofi Consumer Healthcare India Limited made to the Company disclosing the appointment of Independent Directors each for a term of five years. Regulatory Filings	2024-02-21	English

Page 34 of 104

Prev … 32 33 34 35 36 … Next

Market data

Market data not available

Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products

2,202 peers

Company	Ticker	Country	Sector
13260917 Canada Inc. Biotech developing oral small molecules to restore muscle s…	MSCL	CA	Manufacturing
1608557 Ontario Inc. Biopharmaceutical company dedicated to R&D, discovery, and …	OTROQ	CA	Manufacturing
3B BlackBio Dx Limited Develops molecular diagnostic kits for oncology, infectious…	3BBLACKBIO	IN	Manufacturing
3D Medicines Inc. Commercial-stage biopharma specializing in next-generation …	1244	HK	Manufacturing
3SBio Inc. Biopharmaceutical enterprise specializing in R&D, productio…	1530	KY	Manufacturing
4BASEBIO PLC Manufactures GMP-grade synthetic DNA for next-generation th…	4BB	GB	Manufacturing
4D Molecular Therapeutics, Inc. Develops genetic medicines using AAV vectors for ophthalmol…	FDMT	US	Manufacturing
4Front Ventures Corp. Vertically integrated cannabis operator managing cultivatio…	FFNT	CA	Manufacturing
4SC AG Biopharmaceutical company with no products under developmen…	VSC	DE	Manufacturing
60 DEGREES PHARMACEUTICALS, INC. Develops and commercializes medicines for infectious diseas…	SXTP	US	Manufacturing

Page 1 of 221

1 2 3 … Next

Sanofi India Ltd via the API

Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.

Get API access Read API reference

Base URLapi.financialreports.eu

Auth headerx-api-key

Company ID59270

TickerSANOFI

ISININE058A01010

Endpoints

most-used routes for this company

GET	/api/companies/59270/	Company identity, sector, listing, identifiers
GET	/api/filings/?company=59270	Paginated list of all filings (filterable by type, date, language)
GET	/api/filings/{id}/	Single filing — metadata, document URL, processing status
GET	/api/filings/{id}/markdown/	Filing content as Markdown (PDF → text/tables/figures)
GET	/api/isins/?company=59270	All ISINs registered to this company
GET	/api/filing-types/	Reference: every filing-type code + category

Full reference: API reference · OpenAPI schema

cURL

latest filings for Sanofi India Ltd

$ curl https://api.financialreports.eu/api/filings/?company=59270 \
    -H "x-api-key: $FR_API_KEY" \
    -H "Accept: application/json"

Python

requests

import requests

r = requests.get(
    "https://api.financialreports.eu/api/filings/",
    params={"company": 59270},
    headers={"x-api-key": API_KEY},
)
filings = r.json()["results"]

MCP server

Claude · Claude Code · ChatGPT

Claude setup ChatGPT setup Claude Code setup

// MCP server URL
https://mcp.financialfilings.com/mcp

// Once connected, the LLM can query this company directly:
"Pull the latest 5 filings for Sanofi India Ltd (id: 59270)"

Sanofi India Ltd — Investor Relations & Filings